3,0
22. Jän. 2014
Mitarbeiter (anonym)
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Best products compared to competition, patient focused, invests heavily in R&D to bring the absolute best products to market for the safest and best possible care in cancer
Kontras
Very low earning compared to other device/capital companies, continuous changes to comp structure, leadership turnover, realignments of territories and also jobs happen yearly, dis-trust of leadership breeds very low morale among employees